Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
1/28/2026
CDE Issues New Technical Guidance for Clinical Trials of Long-Acting L...
1/28/2026
NMPA Releases 101st Batch of Reference Formulations for Generic Drug E...
1/27/2026
China Issues Revised Implementing Regulations for the Drug Administrat...
1/26/2026
CDE Issues Technical Guidance on NMR Studies for Glycoconjugate Vaccin...
1/26/2026
NMPA Suspends Import, Sale and Use of Sun Pharma's Rivastigmine Capsul...
1/26/2026
NMPA Suspends Import and Use of Chlorpheniramine Maleate API from Supr...
1/23/2026
CDE Seeks Public Feedback on Draft ICH E22 Guideline on Patient Prefer...
1/23/2026
CDE Invites Public Comment on Draft Guideline for Physicochemical and ...
1/22/2026
China Unveils New Policy to Transform Pharmacies into Community Health...
1/22/2026
CDE Seeks Public Input on Draft Guidance for Risk Assessment and Contr...
1/22/2026
NMPA Issues New Guidance to Standardize Vaccine Adjuvant Research, Boo...
1/21/2026
CDE Issues Draft Guidance on Using Bayesian External Data in Drug Clin...
1/19/2026
NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guidelines for Drug ...
1/16/2026
China's NMPA to Mandate eCTD Submission Starting March 1
1/9/2026
NHSA Seeks Comments on Draft Rules for Early Communication on Comparat...
1/9/2026
China Issues New Procedures for Post-Approval Filing Changes to Overse...
1/8/2026
China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...
1/8/2026
China Revises Drug Administration Law Implementation Rules to Boost In...
1/8/2026
China to Implement ICH E6(R3) Guideline for Drug Clinical Trial Qualit...
1/8/2026
NMPA Clarifies Application of ICH Q12 to Strengthen Pharmaceutical Lif...
1/8/2026
NMPA Moves to Accelerate Approval of Overseas-Approved Drugs for Urgen...
1/7/2026
NMPA Issues Announcement on Strengthening Oversight of Contract Drug M...
1/6/2026
China Solicits Comments on 102nd Batch of Reference Formulations for C...
1/4/2026
China Sets New Records in Innovative Drug Approvals and Overseas Licen...
1/4/2026
China Issues Fourth Batch of Encouraged Generic Drug List to Strengthe...
1/4/2026
China Solicits Comments on Draft List of Newly Appointed External Drug...
1/1/2026
CDE Issues the Technical Guidelines for Using Single-Arm Clinical Tria...
1/1/2026
CDE Issues Technical Guidelines for Clinical Trials of Eosinophilic Es...
1/1/2026
CDE Issues Technical Guidelines for Clinical Trials of Drugs Treating ...
1/1/2026
CDE Releases Technical Guidelines for Targeted Biologics in Chronic Ai...
Page:
1
/
8
Total number of articles:
215
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit